Barlow RJ - Search Results

1

Plasmapheresis for severe, unremitting, chronic urticaria.

Grattan CE, Francis DM, Slater NG, Barlow RJ, Greaves MW. Grattan CE, et al. Among authors: barlow rj. Lancet. 1992 May 2;339(8801):1078-80. doi: 10.1016/0140-6736(92)90666-q. Lancet. 1992. PMID: 1373787

2

Warfarin in the treatment of chronic urticaria/angio-edema.

Barlow RJ, Greaves MW. Barlow RJ, et al. Br J Dermatol. 1992 Apr;126(4):415-6. doi: 10.1111/j.1365-2133.1992.tb00694.x. Br J Dermatol. 1992. PMID: 1571267 No abstract available.

3

Adhesion molecule expression and the inflammatory cell infiltrate in delayed pressure urticaria.

Barlow RJ, Ross EL, MacDonald D, Black AK, Greaves MW. Barlow RJ, et al. Br J Dermatol. 1994 Sep;131(3):341-7. doi: 10.1111/j.1365-2133.1994.tb08521.x. Br J Dermatol. 1994. PMID: 7522516

4

The effects of topical corticosteroids on delayed pressure urticaria.

Barlow RJ, Macdonald DM, Black AK, Greaves MW. Barlow RJ, et al. Arch Dermatol Res. 1995;287(3-4):285-8. doi: 10.1007/BF01105080. Arch Dermatol Res. 1995. PMID: 7541190 Clinical Trial.

5

Mast cells and T lymphocytes in chronic urticaria.

Barlow RJ, Ross EL, MacDonald DM, Kobza Black A, Greaves MW. Barlow RJ, et al. Clin Exp Allergy. 1995 Apr;25(4):317-22. doi: 10.1111/j.1365-2222.1995.tb01049.x. Clin Exp Allergy. 1995. PMID: 7600377

6

Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria.

Barlow RJ, Warburton F, Watson K, Black AK, Greaves MW. Barlow RJ, et al. J Am Acad Dermatol. 1993 Dec;29(6):954-8. doi: 10.1016/0190-9622(93)70273-v. J Am Acad Dermatol. 1993. PMID: 8245260

7

Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment.

Barr RM, Lawlor F, Judge MR, Courtney P, Barlow R, Kobza Black A, Mallet AI, Greaves MW. Barr RM, et al. Br J Clin Pharmacol. 1993 Jun;35(6):637-41. doi: 10.1111/j.1365-2125.1993.tb04194.x. Br J Clin Pharmacol. 1993. PMID: 8329291 Free PMC article.

8

Increased interleukin 6, but reduced interleukin 1, in delayed pressure urticaria.

Lawlor F, Bird C, Camp RD, Barlow R, Barr RM, Kobza-Black A, Judge MR, Greaves MW. Lawlor F, et al. Br J Dermatol. 1993 May;128(5):500-3. doi: 10.1111/j.1365-2133.1993.tb00225.x. Br J Dermatol. 1993. PMID: 8504039

9

Intravenous immunoglobulin in autoimmune chronic urticaria.

O'Donnell BF, Barr RM, Black AK, Francis DM, Kermani F, Niimi N, Barlow RJ, Winkelmann RK, Greaves MW. O'Donnell BF, et al. Among authors: barlow rj. Br J Dermatol. 1998 Jan;138(1):101-6. doi: 10.1046/j.1365-2133.1998.02033.x. Br J Dermatol. 1998. PMID: 9536230 Clinical Trial.

10

Human leucocyte antigen class II associations in chronic idiopathic urticaria.

O'Donnell BF, O'Neill CM, Francis DM, Niimi N, Barr RM, Barlow RJ, Kobza Black A, Welsh KI, Greaves MW. O'Donnell BF, et al. Among authors: barlow rj. Br J Dermatol. 1999 May;140(5):853-8. doi: 10.1046/j.1365-2133.1999.02815.x. Br J Dermatol. 1999. PMID: 10354022

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

498 results

Search Page

Filters